Showing results (41-50 of 120) with videos related to
Sort By:
Pageof 12
Carcinogenesis|December 23, 2003
Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profilingJanet C Lindsey, Meryl E Lusher, Jennifer A Anderton, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group databaseRochelle Bagatell, Maja Beck-Popovic, Wendy B London, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2012
Adaptive dosing approaches to the individualization of 13-cis-retinoic acid (isotretinoin) treatment for children with high-risk neuroblastomaGareth J Veal, Julie Errington, Sophie E Rowbotham, et al.Neoplasia (New York, N.Y.)|May 13, 2025
Response of GEM models of neuroblastoma to cabozantinib assessed by multiparametric magnetic resonance imagingGilberto S Almeida, Philippa King, Albert Hallsworth, et al.Pediatric Blood & Cancer|May 6, 2016
Response Assessment in Paediatric Phase I Trials According to RECIST Guidelines: Survival Outcomes, Patterns of Progression and Relevance of Changes in Tumour MeasurementsFernando Carceller, Francisco J Bautista, Lucy A Fowkes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group projectWendy B London, Victoria Castel, Tom Monclair, et al.Oncotarget|October 8, 2016
A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumorsAndrew D J Pearson, Sara M Federico, Isabelle Aerts, et al.European Journal of Cancer (Oxford, England : 1990)|May 18, 2016
Phase 1 study of dalotuzumab monotherapy and ridaforolimus-dalotuzumab combination therapy in paediatric patients with advanced solid tumoursDidier Frappaz, Sara M Federico, Andrew D J Pearson, et al.Cancer Research and Treatment|March 22, 2017
Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN StudyLoredana Amoroso, Giovanni Erminio, Guy Makin, et al.Plos One|July 14, 2017
In vitro nuclear magnetic resonance spectroscopy metabolic biomarkers for the combination of temozolomide with PI3K inhibition in paediatric glioblastoma cellsNada M S Al-Saffar, Alice Agliano, Lynley V Marshall, et al.Pageof 12